However, whether and to what extent NAD+ metabolic disorder can affect Sirt1/ NF-κB P65/FN remains to be further studied for better understanding of the determinants of Sirt1 beneficial effects in DN. The gene discussed is FN1; the disease is liver dysplastic nodule.